)
)
)
Daniel McHugh
Lead Investor
,
Yosemite
Dan leads the investment team at Yosemite, where he oversees the firm’s investments in therapeutics and digital health companies in the oncology space. Prior to helping launch Yosemite, Dan spent seven years at Emerson Collective, where he led the team’s cancer-focused investment efforts. He has held several biotech operating roles, including serving as interim CEO of Tune Therapeutics, a clinical-stage epigenetic editing company. Earlier in his career, Dan worked with biotech and private equity clients at Bain & Company. He holds a B.S. in Bioengineering and an M.S. in Management Science & Engineering from Stanford University.
){kind=logo}
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
